• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

Alzheimer's disease (AD) is a progressive neurodegenerative disease mostly affecting the
elderly population. It is characterized by cognitive decline that occurs due to impaired …

An important update has been made to the estimation of the prevalence of YLD due to IHD.
Previously, the prevalence of IHD represented the aggregate of 3 separately estimated IHD …

Current cardiometabolic disease prevention guidelines recommend increasing dietary
unsaturated fat intake while reducing saturated fats. Here we use lipidomics data from a …

Background Obicetrapib, a novel, selective cholesteryl ester transfer protein (CETP)
inhibitor, reduces low-density lipoprotein cholesterol (LDL-C), LDL particles, apolipoprotein …

Cardiovascular disease (CVD) remains the leading cause of morbidity and mortality
worldwide and challenges the capacity of health care systems globally. Atherosclerosis is …

Background Epidemiological evidence on the association of PM 2.5 (particulate matter with
aerodynamic diameter≤ 2.5 μm) and its specific components with hypertension and blood …

Introduction Despite the technological advancements in catheter ablation strategies, the
recurrence of atrial fibrillation (AF) post-ablation remains a concern that requires further …

Abstract Background The triglyceride-glucose (TyG) index and its combination with obesity
indicators can predict cardiovascular diseases (CVD). However, there is limited research on …

Cardiovascular diseases remain the number one cause of death globally. Cardiovascular
disease risk scores are an integral tool in primary prevention, being used to identify …